Ingevity (NGVT) Tops Q1 EPS by 20c

Ingevity (NYSE: NGVT) reported Q1 EPS of $0.52, $0.20 better than the analyst estimate of $0.32. Revenue for the quarter came in at $340.1 million versus the consensus estimate of $318.75 million.

For earnings history and earnings-related data on Ingevity (NGVT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c